Protalix BioTherapeutics logo
Protalix BioTherapeutics PLX
$ 1.74 0.0%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Protalix BioTherapeutics Total Non Current Liabilities 2011-2024 | PLX

Annual Total Non Current Liabilities Protalix BioTherapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
5.34 M 34 M 46.5 M 8.5 M 75.5 M 88.7 M 80.8 M 26 M 75.1 M 108 M 114 M 56.3 M 59.2 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
114 M 5.34 M 59.8 M

Quarterly Total Non Current Liabilities Protalix BioTherapeutics

2024-Q3 2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
4.91 M 4.99 M 5.96 M 26.3 M 34 M 34 M 33.9 M 39.6 M 40.5 M 46.5 M 40.5 M 8.12 M 7.43 M 8.5 M 8.5 M 8.5 M 8.5 M 75.5 M 75.5 M 75.5 M 75.5 M 88.7 M 88.7 M 88.7 M 88.7 M 78.9 M 78.9 M 78.9 M 78.9 M 26 M 26 M 26 M 26 M 75.1 M 75.1 M 75.1 M 75.1 M 69.6 M 108 M 108 M 108 M 114 M 114 M 114 M 114 M 56.3 M 56.3 M 56.3 M 56.3 M 59.2 M 59.2 M 59.2 M 59.2 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
114 M 4.91 M 57.5 M